SGC-0946
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 407107

CAS#: 1561178-17-3

Description: SGC-0946 is a potent and selective inhibitor of DOT1L, which potently and selectively kills cells containing an MLL translocation. SGC0946 inhibits DOT1L with an IC50 of 0.3nM in a radioactive enzyme assay and is over 100-fold selective for other HMTs. In addition, SGC-0946 potently reduces H3K79 dimethylation with cellular IC50 of 2.6nM in A431 cells, and 8.8nM in MCF10A cells.


Chemical Structure

img
SGC-0946
CAS# 1561178-17-3

Theoretical Analysis

MedKoo Cat#: 407107
Name: SGC-0946
CAS#: 1561178-17-3
Chemical Formula: C28H40BrN7O4
Exact Mass: 617.23
Molecular Weight: 618.580
Elemental Analysis: C, 54.37; H, 6.52; Br, 12.92; N, 15.85; O, 10.35

Price and Availability

Size Price Availability Quantity
10mg USD 150 Ready to ship
25mg USD 250 Ready to ship
50mg USD 450 Ready to ship
100mg USD 750 Ready to ship
200mg USD 1250 Ready to ship
500mg USD 2850 2 Weeks
1g USD 3850 2 Weeks
2g USD 6450 2 weeks
Bulk inquiry

Synonym: SGC-0946; SGC 0946; SGC0946.

IUPAC/Chemical Name: 1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-isobutylphenyl)urea

InChi Key: UZLAJVZJBSZSJL-VBHAUSMQSA-N

InChi Code: InChI=1S/C28H40BrN7O4/c1-16(2)12-18-6-8-19(9-7-18)34-28(39)31-10-5-11-35(17(3)4)14-21-23(37)24(38)27(40-21)36-13-20(29)22-25(30)32-15-33-26(22)36/h6-9,13,15-17,21,23-24,27,37-38H,5,10-12,14H2,1-4H3,(H2,30,32,33)(H2,31,34,39)/t21-,23-,24-,27-/m1/s1

SMILES Code: O=C(NC1=CC=C(CC(C)C)C=C1)NCCCN(C[C@H]2O[C@@H](N3C=C(Br)C4=C(N)N=CN=C43)[C@H](O)[C@@H]2O)C(C)C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target: SGC-0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM.
In vitro activity: SGC-0946 treatment led to reduction in H3K79me2 72 hours posttreatment and more significantly 7 days post-treatment. SGC-0946 reduced the expression of the DOT1L and N-Myc target gene E2F2 and dose-dependently reduced BE(2)-C and Kelly cells' proliferation. In contrast, treatment with SGC-0946 did not reduce E2F2 gene expression and did not have an effect on cell proliferation in MYCN gene nonamplified NBL-S and SK-N-FI neuroblastoma cells. Reference: Cancer Res. 2017 May 1;77(9):2522-2533. https://pubmed.ncbi.nlm.nih.gov/28209620/
In vivo activity: O. moubata, a type of tick, larvae exposed to SGC-0946 displayed high mortality during molting to first-stage nymphs. However artificial blood feeding supplemented with SGC-0946 did not affect survival and reproductive performance of adult female ticks. Reference: Vaccines (Basel). 2020 Apr 1;8(2):157. https://pubmed.ncbi.nlm.nih.gov/32244625/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 55.5 89.67
DMF 10.0 16.17
Ethanol 57.3 92.61
Ethanol:PBS (pH 7.2) (1:4) 0.2 0.32

Preparing Stock Solutions

The following data is based on the product molecular weight 618.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Wong M, Tee AEL, Milazzo G, Bell JL, Poulos RC, Atmadibrata B, Sun Y, Jing D, Ho N, Ling D, Liu PY, Zhang XD, Hüttelmaier S, Wong JWH, Wang J, Polly P, Perini G, Scarlett CJ, Liu T. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Cancer Res. 2017 May 1;77(9):2522-2533. doi: 10.1158/0008-5472.CAN-16-1663. Epub 2017 Feb 16. PMID: 28209620. 2. Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J, Marcellus R, Iacob RE, Engen JR, Griffin C, Aman A, Wienholds E, Li F, Pineda J, Estiu G, Shatseva T, Hajian T, Al-Awar R, Dick JE, Vedadi M, Brown PJ, Arrowsmith CH, Bradner JE, Schapira M. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun. 2012;3:1288. doi: 10.1038/ncomms2304. Erratum in: Nat Commun. 2013;4:1893. PMID: 23250418. 3. Chava S, Bugide S, Edwards YJK, Gupta R. Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis. Oncogenesis. 2021 Jul 12;10(7):48. doi: 10.1038/s41389-021-00339-6. PMID: 34253709; PMCID: PMC8275629. 4. Gobl J, Kumar Sinha D, Sima R, Perner J, Kopáček P, Valdés JJ, Rego ROM, Cabezas-Cruz A. Histone Methyltransferase DOT1L is Involved in Larval Molting and Second Stage Nymphal Feeding in Ornithodoros Moubata. Vaccines (Basel). 2020 Apr 1;8(2):157. doi: 10.3390/vaccines8020157. PMID: 32244625; PMCID: PMC7349889.
In vitro protocol: 1. Wong M, Tee AEL, Milazzo G, Bell JL, Poulos RC, Atmadibrata B, Sun Y, Jing D, Ho N, Ling D, Liu PY, Zhang XD, Hüttelmaier S, Wong JWH, Wang J, Polly P, Perini G, Scarlett CJ, Liu T. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Cancer Res. 2017 May 1;77(9):2522-2533. doi: 10.1158/0008-5472.CAN-16-1663. Epub 2017 Feb 16. PMID: 28209620. 2. Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J, Marcellus R, Iacob RE, Engen JR, Griffin C, Aman A, Wienholds E, Li F, Pineda J, Estiu G, Shatseva T, Hajian T, Al-Awar R, Dick JE, Vedadi M, Brown PJ, Arrowsmith CH, Bradner JE, Schapira M. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun. 2012;3:1288. doi: 10.1038/ncomms2304. Erratum in: Nat Commun. 2013;4:1893. PMID: 23250418.
In vivo protocol: 1. Chava S, Bugide S, Edwards YJK, Gupta R. Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis. Oncogenesis. 2021 Jul 12;10(7):48. doi: 10.1038/s41389-021-00339-6. PMID: 34253709; PMCID: PMC8275629. 2. Gobl J, Kumar Sinha D, Sima R, Perner J, Kopáček P, Valdés JJ, Rego ROM, Cabezas-Cruz A. Histone Methyltransferase DOT1L is Involved in Larval Molting and Second Stage Nymphal Feeding in Ornithodoros Moubata. Vaccines (Basel). 2020 Apr 1;8(2):157. doi: 10.3390/vaccines8020157. PMID: 32244625; PMCID: PMC7349889.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Wenyu Yu, Emma J. Chory, Amy K. Wernimont, Wolfram Tempel, Alex Scopton, Alexander Federation, Jason J. Marineau, Jun Qi, Dalia Barsyte-Lovejoy, Joanna Yi, Richard Marcellus, Roxana E. Iacob, John R. Engen, Erno Wienholds, Fengling Li, Javier Pineda, Guillermina Estiu, Tatiana Shatseva, Taraneh Hajian, Rima Al-awar, John E. Dick, Masoud Vedadi, Peter J. Brown, Cheryl H. Arrowsmith*, James E. Bradner*, Matthieu Schapira*. Nature Communications 3 : 1288doi:10.1038/ncomms2304 (2012)